1. Home
  2. IRD vs ECG Comparison

IRD vs ECG Comparison

Compare IRD & ECG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRD
  • ECG
  • Stock Information
  • Founded
  • IRD 2018
  • ECG 1995
  • Country
  • IRD United States
  • ECG United States
  • Employees
  • IRD N/A
  • ECG N/A
  • Industry
  • IRD
  • ECG
  • Sector
  • IRD
  • ECG
  • Exchange
  • IRD NYSE
  • ECG NYSE
  • Market Cap
  • IRD 62.0M
  • ECG 3.1B
  • IPO Year
  • IRD N/A
  • ECG N/A
  • Fundamental
  • Price
  • IRD $1.02
  • ECG $65.16
  • Analyst Decision
  • IRD Strong Buy
  • ECG Buy
  • Analyst Count
  • IRD 3
  • ECG 3
  • Target Price
  • IRD $6.33
  • ECG $73.00
  • AVG Volume (30 Days)
  • IRD 803.8K
  • ECG 324.9K
  • Earning Date
  • IRD 08-15-2025
  • ECG 08-15-2025
  • Dividend Yield
  • IRD N/A
  • ECG N/A
  • EPS Growth
  • IRD N/A
  • ECG 14.34
  • EPS
  • IRD N/A
  • ECG 2.98
  • Revenue
  • IRD $13,651,000.00
  • ECG $3,050,625,000.00
  • Revenue This Year
  • IRD $51.41
  • ECG $9.73
  • Revenue Next Year
  • IRD $68.84
  • ECG $10.17
  • P/E Ratio
  • IRD N/A
  • ECG $21.88
  • Revenue Growth
  • IRD N/A
  • ECG 11.77
  • 52 Week Low
  • IRD $0.65
  • ECG $31.38
  • 52 Week High
  • IRD $2.18
  • ECG $77.93
  • Technical
  • Relative Strength Index (RSI)
  • IRD N/A
  • ECG N/A
  • Support Level
  • IRD N/A
  • ECG N/A
  • Resistance Level
  • IRD N/A
  • ECG N/A
  • Average True Range (ATR)
  • IRD 0.00
  • ECG 0.00
  • MACD
  • IRD 0.00
  • ECG 0.00
  • Stochastic Oscillator
  • IRD 0.00
  • ECG 0.00

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

About ECG EVERUS CONSTRUCTION GROUP INC

Everus Construction Group Inc is a construction solutions provider, offering specialty contracting services to a diverse set of end markets across the U.S. It operates across two segments Electrical & Mechanical (E&M) and Transmission & Distribution (T&D), and delivers services through its subsidiaries. It generates the majority of revenue from the Electrical & Mechanical segment which offers a wide variety of specialty contracting services, including construction and maintenance of electrical and communication wiring, fire suppression systems, and mechanical piping and services, to customers in both the public and private sectors. Its T&D segment serves electric and natural gas utility customers, as well as customers in the transportation end market, in the West and Midwest regions.

Share on Social Networks: